Phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with ovarian, fallopian tube or primary peritoneal carcinoma.
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 23 Nov 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 10 Nov 2009 Planned end date changed from 1 Sep 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.